Thomas J Smith, MD in Altadena, CA - Ophthalmology

Thomas J Smith, MD is a Ophthalmology physician based in Altadena, California. Thomas J Smith is licensed to practice in Massachusetts (license number 75739) and his current practice location is 240 Taos Rd, Altadena, California. He can be reached at his office (for appointments etc.) via phone at (626) 376-4070.

NPI number for Thomas J Smith is 1053475285 and his current mailing address is 240 Taos Rd, Altadena, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1053475285.

Contact Information

	Thomas J Smith, MD
	240 Taos Rd, Altadena, CA 91001-3953
	(626) 376-4070
	Not Available

Physician's Profile

Full Name	Thomas J Smith
Gender	Male
Speciality	Ophthalmology
Location	240 Taos Rd, Altadena, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1053475285
Provider Enumeration Date: 12/21/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Thomas J Smith such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053475285	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	75739 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas J Smith is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Thomas J Smith, MD 240 Taos Rd, Altadena, CA 91001-3953 Ph: (626) 376-4070	Thomas J Smith, MD 240 Taos Rd, Altadena, CA 91001-3953 Ph: (626) 376-4070

News Archive

Regulatory differences between mother and daughter cells shed new light on cell division

When mother and daughter cells are created each time a cell divides, they are not exactly alike. They have the same set of genes, but differ in the way they regulate them. New research now reveals that these regulatory differences between mother and daughter cells are directly linked to how they prepare for their next split.

Town Sports fourth quarter total revenue decreases 0.2%

Town Sports International Holdings, Inc., a leading owner and operator of health clubs located primarily in major cities from Washington, DC north through New England, operating under the brand names "New York Sports Clubs," "Boston Sports Clubs," "Washington Sports Clubs" and "Philadelphia Sports Clubs," announced its results for the fourth quarter and full-year ended December 31, 2010.

Trauma surgeon co-authors call to action to establish pediatric trauma research network

Jeffrey S. Upperman, MD, director of the Trauma Program at Children's Hospital Los Angeles, has co-authored a call to action for filling a significant gap in pediatric public health care and seeks federal oversight to establish the framework for a pediatric applied trauma research network (PATRN). This call to action was published simultaneously in the Journal of Pediatric Surgery and the Journal of Trauma.

Graphene-based electrodes could be safely implanted in the brain

Researchers have successfully demonstrated how it is possible to interface graphene - a two-dimensional form of carbon - with neurons, or nerve cells, while maintaining the integrity of these vital cells. The work may be used to build graphene-based electrodes that can safely be implanted in the brain, offering promise for the restoration of sensory functions for amputee or paralysed patients, or for individuals with motor disorders such as epilepsy or Parkinson's disease.

Nanomix announces closure of private financing for $12M

Nanomix Inc., (Nanomix), a leading nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, today announced that is has closed private financing for approximately $12 million.

Thomas J Smith, MD - Ophthalmology in Altadena, CA